Your browser doesn't support javascript.
loading
[Patients with type III obesity given sibutramine 15 mg/day lose weight in amounts proportional to those in types I and II, but waist circumferences does not decrease proportionally]. / El grado de obesidad modifica la respuesta de disminución de circunferencia de cintura en pacientes que reciben 15 mg diarios de sibutramina. Estudio abierto sobre tolerancia y efectividad de la sibutramina.
López-Alvarenga, Juan Carlos; Vargas, José Antonio; Schneider-Ehrenberg, Oliver Paul; Comuzzie, Anthony G; González, Jorge; Martínez, José Luis.
Afiliación
  • López-Alvarenga JC; Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, Texas, USA. jalvaren@darwin.sfbr.org
Gac Med Mex ; 143(2): 109-14, 2007.
Article en Es | MEDLINE | ID: mdl-17585697
OBJECTIVE: The etiology, comorbidity, metabolism, and treatment response vary among overweight and obesity types I, II and III individuals. We assessed the association between obesity type with body mass index, waist circumference and tolerance to a daily dose of 15 mg of sibutramine. MATERIALS AND METHODS: A sample of 701 individuals recruited from 47 health centers was analyzed. All subjects received 15 mg of sibutramine daily for 8 weeks. Weight, height, and waist circumference were measured at day 0 and weeks 4 and 8. RESULTS: Patients in all obesity types lost proportional amounts of weight (p=0.86), but those in type IIl obesity had a smaller reduction in waist circumference than those in types I and 1 (p=0.003). Side effects of sibutramine were rarely observed. Subjects with type III obesity exhibited even fewer side effects. CONCLUSIONS: The lack of association between weight reduction and decreased waist circumference across obesity types could be related to differences in the sympathetic nervous system or to sibutramine biodistribution. Subjects with body mass index greater than 40 Kg/ m(2) required a higher dose of sibutramine in order to loose the same proportion of abdominal fat as those in other types of obesity.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Depresores del Apetito / Pérdida de Peso / Ciclobutanos / Grasa Abdominal / Obesidad Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Es Revista: Gac Med Mex Año: 2007 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: México
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Depresores del Apetito / Pérdida de Peso / Ciclobutanos / Grasa Abdominal / Obesidad Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Es Revista: Gac Med Mex Año: 2007 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: México